Projekt
A randomized phase II trial of pertuzumab in combination with trastuzumab with or without chemotherapy, both followed by T-DM1 in case of progression, in patients with HER2-positive metastatic breast cancer
Automatisch geschlossen · 2013 bis 2019
Weder Patrik, Thürlimann Beat, Ruhstaller Thomas, Maier Reinhard, Riniker Salome, Öhlschlegel Christian, Hasler-Strub Ursula
Weder, Patrik
9
13
Thürlimann, Beat
259
14
Ruhstaller, Thomas
83
24
Maier, Reinhard
Leitung Clinical Trials Unit (CTU) (operationell)wissenschaftliche(r) Mitarbeiter/in
Medizinisches Forschungszentrum, Clinical Trials Unit · Dept. Direktion
24
5
Riniker, Salome
4
11
Öhlschlegel, Christian
40
4
Hasler-Strub, Ursula
5
11